Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference
Globe Newswire•27/10/2026•16:01 ET
0
Key Highlights
- ➤Cogent to participate in Guggenheim Healthcare Innovation Conference fireside chat November 10
- ➤Live webcast and replay scheduled through Cogent’s Investors & Media page
- ➤Six new employees received inducement awards totaling 22,000 options and 16,500 RSUs
- ➤Options carry 10-year terms and four-year vesting schedules
- ➤Bezuclastinib targets KIT mutations implicated in Systemic Mastocytosis and advanced GIST
WALTHAM, Mass. and BOULDER, Colo., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its participation in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on Tuesday, November 10, 2026 at 7:30 a.m. ET.
A live webcast can be accessed on the Investors & Media page of Cogent’s website at https://investors.cogentbio.com/events. A replay will be available approximately two hours after the completion of the event and will be archived for up to 30 days.
Get started
Create a free account to read the full story.